Szent-Györgyi Prize Archives - Page 3 of 5 - NFCR

Szent-Györgyi Prize

Web Cavenee: In the Genes

In 2016, archeologists working in the Swartkrans Cave in South Africa found a piece of foot bone belonging to a hominid dating back 1.6 to 1.8 million years. This alone would create a buzz among scientists. But it was what was on the bone that generated headlines: This ancient human…...

Read more

Dr. Michael Hall on Why Funding is So Important for Cancer Research

Dr. Hall and many other scientist’s innovative research would not be possible without support and funding from private foundations such as the National Foundation for Cancer Research. See why Dr. Hall believes funding plays such an important role in cancer research....

Read more

Harold Dvorak: The Trailblazer

“Tumors are wounds that don’t heal,” says Harold Dvorak, M.D., and if that sounds like an overly simplification, it is a foregone conclusion that some of the most complicated problems have very simple beginnings. A scientists funded by the National Foundation for Cancer Research (NFCR) from 1980 to 2016, Dr.…...

Read more

An Evening Honoring Tremendous Achievement in Cancer Prevention

The National Foundation for Cancer Research’s (NFCR) annual marquee event was held in Washington, DC on Saturday evening, May 5th. The 2018 Szent-Györgyi Prize for Progress in Cancer Research ceremony and dinner occasioned much, including a gathering of NFCR principals and scientists, communication of the Foundation’s mandate, messages from the…...

Read more

Douglas Lowy & John Schiller: An Ounce of Prevention

When Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., receive the 2018 Albert Szent-Györgyi Prize for Cancer Research, it will set a precedent for the honor itself. By creating an effective vaccine for the human papillomavirus (HPV), cause of practically all cervical tumors, Lowy and Schiller forged a means…...

Read more

Michael Hall: TOR de Force

The discovery of rapamycin in 1972 did not create major waves in the oncology community. But in 1989, Michael N. Hall, Ph.D., took a second look, screening yeast cells for rapamycin resistance. That led to the discovery of TOR, or “Target of Rapamycin,” and one of the most profound paradigm…...

Read more

2018 Szent-Györgyi Prize Invite

2018 Szent-Györgyi Prize will be awarded to Douglas R. Lowy, M.D., and John T. Schiller, Ph.D. for the development of vaccines for human papilloma virus (HPV). When:  Saturday May 5th, 2018 6:00 pm Where:  Ronald Reagan Building and International Trade Center 1300 Pennsylvania Avenue, NW Washington, DC  20004 Dress Code: Cocktail Attire…...

Read more

Duo of Oncology Vaccine Pioneers at the National Cancer Institute to Receive 2018 Annual Szent-Györgyi Prize for Progress in Cancer Research

  FOR IMMEDIATE RELEASE: February 15, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org First Occasion for Award to Recognize Extraordinary Contributions in Cancer Prevention, Role of Vaccines BETHESDA, MD – The National Foundation for Cancer Research (NFCR) announced today that the 2018 Szent-Györgyi Prize…...

Read more

The Full Story of Dr. Albert Szent-Györgyi

Learn about the Vitamin-C studying, Nobel-Prize winning co-founder of the National Foundation for Cancer Research, Dr. Albert Szent-Györgyi....

Read more

Dr. Jim Allison: Cancer Immunotherapy Pioneer

Szent-Györgyi Prize Winners: Then & Now The Szent-Györgyi Prize was established in honor of Nobel laureate Dr. Albert Szent-Györgyi, co-founder of NFCR, to recognize outstanding scientific achievement in the war against cancer. Ten years later, “ASG Winners: Then & Now” looks at these winners, their extraordinary contributions and how their discoveries have made possible new…...

Read more